Risk factors for developing pneumomediastinum include the presence of ILD, cutaneous vasculopathy, prior systemic corticosteroid use, young age, minimal elevation of creatine kinase, detectable anti-MDA5, and prior reductions in vital capacity and carbon monoxide diffusing capacity [3]. This evidence concerns the gene IFIH1 and interstitial lung disease.